Cardiovascular Systems, Inc.
CSII · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $61 | $60 | $62 | $56 |
| % Growth | 3% | -4.5% | 11.2% | – |
| Cost of Goods Sold | $18 | $17 | $16 | $15 |
| Gross Profit | $43 | $43 | $46 | $41 |
| % Margin | 70% | 72% | 74% | 73.7% |
| R&D Expenses | $10 | $9 | $9 | $9 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $42 | $44 | $47 | $42 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $52 | $54 | $56 | $51 |
| Operating Income | -$9 | -$11 | -$9 | -$10 |
| % Margin | -13.9% | -18.3% | -15.2% | -17.2% |
| Other Income/Exp. Net | $1 | $0 | -$0 | $0 |
| Pre-Tax Income | -$8 | -$11 | -$10 | -$10 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$8 | -$11 | -$10 | -$10 |
| % Margin | -12.8% | -17.8% | -15.5% | -17.2% |
| EPS | -0.2 | -0.27 | -0.25 | -0.25 |
| % Growth | 25.9% | -8% | 0% | – |
| EPS Diluted | -0.2 | -0.27 | -0.25 | -0.25 |
| Weighted Avg Shares Out | 40 | 40 | 39 | 39 |
| Weighted Avg Shares Out Dil | 40 | 40 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $2 | $0 | $0 |
| EBITDA | -$7 | -$9 | -$9 | -$9 |
| % Margin | -11.5% | -15.1% | -14.2% | -15.7% |